Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...

The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

GLP-1 drug users initially spend less on groceries, but that levels out over the next year, shows Circana's analysis of food ...

Ozempic, an anti-diabetes medication, has gained popularity for its off-label use in weight loss among celebrities, despite ...

The new definition proposed by the Lancet Diabetes & Endocrinology Commission, a group of 58 leading experts from various ...